What Are Peptides for Gut

(default writer prompt)

input: Write a data-first, evidence-graded article: What Are Peptides for Gut
Slug: what-are-peptides-gut
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_layers":[],"note":"No 

{
  "slug": "what-are-peptides-gut",
  "title": "What Are Peptides for Gut",
  "body": "## What's breaking down\n\nGut tissue faces constant mechanical, chemical, and microbial stress. The intestinal lining must balance rapid cell turnover with barrier integrity. When repair pathways lag behind daily damage from diet, inflammation, or medications, the mucosa thins, tight junctions loosen, and ulcers or permeability issues can persist. This is a classic regeneration-versus-degeneration imbalance. Peptides derived from or modeled on natural gastric factors are studied mainly for shifting that balance toward repair in animal models rather than merely suppressing symptoms.\n\n## How these fit together\n\nMost discussion centers on a single compound with direct ties to gastric protection. Its studied actions target mucosal repair, angiogenesis, and inflammation control in the gut wall. Any broader stack would map additional layers such as systemic inflammation or motility, but here the focus remains on one pathway cluster.\n\n## What the evidence actually shows\n\nPreclinical work in rats and mice forms the core dataset. Multiple studies induced gastric ulcers or colitis-like damage then administered BPC-157; treated animals showed faster ulcer closure, preserved mucosal architecture, and reduced inflammatory markers compared with controls (source s12, s14). These findings are consi